The We-Met platform started in 2015 at the Institute of Metabolic and Cardiovascular Diseases (I2MC) in Toulouse.

The aim of this platform has always been to provide the very latest innovative technologies and technical support around functional biochemistry.

Based on Alexandre Lucas's skills in biochemistry, the platform provides 3 major poles of technologies : around the western blot, around biomarkers and around the study of cell metabolism by the Seahorse analyser.

 

CONTACTEZ-NOUS